These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2062508)

  • 1. Device drug delivery to the eye. Collagen shields, iontophoresis, and pumps.
    Friedberg ML; Pleyer U; Mondino BJ
    Ophthalmology; 1991 May; 98(5):725-32. PubMed ID: 2062508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic considerations in the treatment of bacterial keratitis.
    Callegan MC; O'Callaghan RJ; Hill JM
    Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of corneal collagen shields as a drug delivery device for the treatment of experimental Pseudomonas keratitis.
    Silbiger J; Stern GA
    Ophthalmology; 1992 Jun; 99(6):889-92. PubMed ID: 1630778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging study of current and ion delivery into the eye during transscleral and transcorneal iontophoresis.
    Li SK; Jeong EK; Hastings MS
    Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1224-31. PubMed ID: 15037591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transscleral and transcorneal iontophoresis of ketoconazole in the rabbit eye.
    Grossman R; Lee DA
    Ophthalmology; 1989 May; 96(5):724-9. PubMed ID: 2748126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen shields delivery of netilmicin: a study of ocular pharmacokinetics.
    Dorigo MT; De Natale R; Miglioli PA
    Chemotherapy; 1995; 41(1):1-4. PubMed ID: 7875016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen shield delivery of tissue plasminogen activator: functional and pharmacokinetic studies of anterior segment delivery.
    Murray TG; Jaffe GJ; McKay BS; Han DP; Burke JM; Abrams GW
    Refract Corneal Surg; 1992; 8(1):44-8; discussion 48-53. PubMed ID: 1554639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen corneal shields.
    Willoughby CE; Batterbury M; Kaye SB
    Surv Ophthalmol; 2002; 47(2):174-82. PubMed ID: 11918897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of fluorescein to the anterior chamber using the corneal collagen shield.
    Reidy JJ; Limberg M; Kaufman HE
    Ophthalmology; 1990 Sep; 97(9):1201-3. PubMed ID: 2234854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagen shield enhancement of topical dexamethasone penetration.
    Hwang DG; Stern WH; Hwang PH; MacGowan-Smith LA
    Arch Ophthalmol; 1989 Sep; 107(9):1375-80. PubMed ID: 2783071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of collagen shields for drug delivery in cataract and intraocular lens surgery.
    Tennen DG; Keates RH
    Curr Opin Ophthalmol; 1995 Feb; 6(1):59-61. PubMed ID: 10150846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of collagen shields in the treatment of herpetic keratitis.
    Colin J; Malet F; Chastel C; Richard MC
    Curr Eye Res; 1991; 10 Suppl():189-91. PubMed ID: 1650666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device.
    Hariprasad SM; Shah GK; Chi J; Prince RA
    J Cataract Refract Surg; 2005 Nov; 31(11):2142-6. PubMed ID: 16412929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
    Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
    Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagen shield delivery of amphotericin B.
    Schwartz SD; Harrison SA; Engstrom RE; Bawdon RE; Lee DA; Mondino BJ
    Am J Ophthalmol; 1990 Jun; 109(6):701-4. PubMed ID: 2346199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis.
    Clinch TE; Hobden JA; Hill JM; O'Callaghan RJ; Engel LS; Kaufmann HE
    CLAO J; 1992 Oct; 18(4):245-7. PubMed ID: 1424060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional ocular gentamicin levels after transcorneal and transscleral iontophoresis.
    Grossman RE; Chu DF; Lee DA
    Invest Ophthalmol Vis Sci; 1990 May; 31(5):909-16. PubMed ID: 2335452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of trifluridine to human cornea and aqueous using collagen shields.
    Kuster P; Taravella M; Gelinas M; Stepp P
    CLAO J; 1998 Apr; 24(2):122-4. PubMed ID: 9571274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of experimental corneal allograft rejection in rabbits using cyclosporin-collagen shields.
    Mahlberg K; Uusitalo RJ; Gebhardt B; Kaufman HE
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(1):69-74. PubMed ID: 2004727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transcorneal and transscleral iontophoresis of the dexamethasone phosphate into the rabbit eye].
    Raiskup-Wolf F; Eljarrat-Binstock E; Rehák M; Domb A; Frucht-Pery J
    Cesk Slov Oftalmol; 2007 Sep; 63(5):360-8. PubMed ID: 17915587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.